Anne Ulbrich
About Anne Ulbrich
Anne Ulbrich is the Senior Medical Manager Oncology at Bristol Myers Squibb, with over 7 years of experience in various roles within the company, specializing in oncology and virology.
Title
Anne Ulbrich holds the position of Senior Medical Manager Oncology at Bristol Myers Squibb. She has progressed through several roles within the company, reflecting her depth of knowledge and expertise in the medical field.
Education and Expertise
Anne Ulbrich has a solid academic background, having earned a Master of Science (M.Sc.) in Molecular Medicine from Friedrich-Schiller-Universität Jena and a Bachelor of Science (B.Sc.) in Biowissenschaften from Ruprecht-Karls-Universität Heidelberg. Her studies equipped her with a comprehensive understanding of molecular science, providing a strong foundation for her career in medical management.
Career at Bristol Myers Squibb
Anne Ulbrich has been with Bristol Myers Squibb for over seven years, beginning her journey as a Praktikant Medical Affairs Virology in 2015. She then became a Medical Project Specialist Virology and later transitioned to roles in oncology, including Medical Science Manager and Medical Advisor. Her diverse roles at the company highlight her adaptability and breadth of medical knowledge, particularly in oncology and virology.
Experience in Oncology
Anne Ulbrich brings extensive experience in oncology to her role, having served as a Medical Science Manager and Medical Advisor in this specialty. Her current position as Senior Medical Manager Oncology further underscores her expertise and commitment to advancing oncology treatments and patient care at Bristol Myers Squibb.
Versatility in Medical Expertise
Anne Ulbrich's career demonstrates her versatility in the medical field, transitioning from virology to oncology roles within Bristol Myers Squibb. This adaptability showcases her ability to apply her scientific knowledge across different medical disciplines, contributing significantly to various projects and initiatives within the company.